BioCentury | Aug 22, 2016
Finance

Northern Lights 2.0

...of one's idea, but my impression is it's not that difficult." Nykjaer co-founded neurology company NeuronIcon ApS...
BioCentury | Sep 16, 2010
Distillery Therapeutics

Indication: Cardiovascular disease

...Sept. 16, 2010 Patent application filed; H. Lundbeck A/S has rights from its acquisition of NeuronIcon ApS...
BioCentury | Jul 13, 2009
Company News

LifeHealth, NeuronIcon, Lundbeck deal

...and is also approved in Australia, France, Germany, Ireland and the U.K. Separately, Lundbeck acquired NeuronIcon...
...the University of Arhus and receive certain undisclosed rights to technology discovered by the university. NeuronIcon...
...by scientists at the university. Financial terms were not disclosed. LifeHealth Ltd. , Berkshire, U.K. NeuronIcon ApS...
Items per page:
1 - 3 of 3
BioCentury | Aug 22, 2016
Finance

Northern Lights 2.0

...of one's idea, but my impression is it's not that difficult." Nykjaer co-founded neurology company NeuronIcon ApS...
BioCentury | Sep 16, 2010
Distillery Therapeutics

Indication: Cardiovascular disease

...Sept. 16, 2010 Patent application filed; H. Lundbeck A/S has rights from its acquisition of NeuronIcon ApS...
BioCentury | Jul 13, 2009
Company News

LifeHealth, NeuronIcon, Lundbeck deal

...and is also approved in Australia, France, Germany, Ireland and the U.K. Separately, Lundbeck acquired NeuronIcon...
...the University of Arhus and receive certain undisclosed rights to technology discovered by the university. NeuronIcon...
...by scientists at the university. Financial terms were not disclosed. LifeHealth Ltd. , Berkshire, U.K. NeuronIcon ApS...
Items per page:
1 - 3 of 3